We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lipid Vesicles Replace Blood in New Bacteria Test

By LabMedica International staff writers
Posted on 04 Oct 2017
Beta-hemolytic bacteria are those pathogens that are frequently to blame for illnesses that are spread among school children like Streptococcus, or those like Listeria that cause many foodborne illnesses. More...
The current test involves streaking a patient sample onto blood agar plates.

Tests do exist for the detection of particular beta-hemolytic species; however, these approaches are commonly based on the detection of genetic or antigenic determinants and not beta-hemolysis. Examples include the antibody–antigen tests, nucleic acid-based assay and more recent approaches using bacteriophages engineered with reporters.

Scientists at the Temasek Life Sciences Laboratory (Singapore) and their colleagues used the original blood agar test as inspiration for their new one. In the new assay, they placed fluorophores inside liposomes, which are lipid vesicles that have been used for controlled drug release. While in the liposome, the fluorescent molecules are packed together and are quenched, or dark, but when in the presence of beta-hemolytic bacteria, the liposome is broken open, the molecules are released, and they fluoresce.

The investigators used bacterial strains which were streaked on sheep blood agar and incubated at 37 °C overnight to check for hemolytic activity. The new test, called BETA, distinguished beta-hemolytic bacteria from control bacteria with 100 % accuracy in six hours on plates, and with 99% accuracy in liquid broth in an hour. The scientists say the method is rapid and cost-effective, which makes it ideal for diagnostics in developing countries. They also noticed that colony fluorescence associated with beta-hemolysis was qualitatively different from background fluorescence associated with control bacteria.

The authors concluded that BETA’s timeliness opens the door to applications once limited by the tardiness of blood agar cultures. With increased speed, gold standard throat cultures based on BETA can now be used as a first-choice diagnostic test (as opposed to a confirmatory assay) for bacterial pharyngitis. BETA’s scalable form-factor (multiwell plates) and low reagent costs (∼USD 0.02 per assay) make it suitable as a sensitive high-throughput triage method for in-plant food safety testing to complement pathogen-specific assays such as phage detection. The study was published on September 20, 2017, in the journal ACS Sensors.

Related Links:
Temasek Life Sciences Laboratory


New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.